Delivery Order V797P5920X-VA663A10324

This federal contract award to Grifols USA LLC, a global healthcare company, is for the pharmaceutical product PROLASTIN-C LIQUID. The contract, valued at $11,502.40, is a delivery order awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 5 (VISN 5). PROLASTIN-C is an alpha1-proteinase inhibitor used to treat alpha1-antitrypsin deficiency. The contract has a firm fixed price and an ultimate completion date of August 23, 2024. Grifols USA LLC holds a Federal...

The Department of Veterans Affairs Veterans Health Administration awarded Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals, a $130,406.43 delivery order contract for PROLASTIN 1000MG/VIAL. The contract is a firm fixed price agreement issued under the Pharmaceuticals and Drugs GSA Schedule. This award does not utilize a small business set-aside. Grifols has previously provided pharmaceutical products such as Prolastin, Prolastin-C, and...

<p>This is a firm fixed-price delivery order awarded by the Veterans Integrated Service Network 16 (a civilian agency of the U.S. government) to Talecris Biotherapeutics Incorporated on July 10, 2012. The award is for the supply of PROLASTIN C, a product used by the Department of Veterans Affairs. The contract has a ceiling value of $9,555.84 and an ultimate completion date of August 21, 2015. The contract does not have a set-aside designation.</p>

This federal contract award is for the delivery of PROLASTIN, a pharmaceutical product, to the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20. The contract was awarded to the prime contractor Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract has a firm fixed price of $202,230.57 and a completion date of January 31, 2019. It was awarded on February 22, 2018 and is a BPA...

This federal contract award is for the drug Prolastin (Prolastin-C, alpha1-proteinase inhibitor) 1000mg/vial injection, with a National Drug Code (NDC) of 13533-0703-10. The contract, worth $193,110.72, was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 20 to Grifols Therapeutics LLC, a for-profit pharmaceutical manufacturer. The contract is a blanket purchase agreement (BPA) call order, with a firm fixed price...

The Department of Veterans Affairs Veterans Health Administration awarded a Blanket Purchase Agreement (BPA) call to Grifols Therapeutics LLC, a for-profit manufacturer of pharmaceuticals and biologics, for the provision of Prolastin-C injections to the Portland VA Medical Center. The BPA call has a potential value of $262,452.48 and was awarded on October 1, 2018, with a completion date of September 30, 2019. The contract was issued under the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB)...

This federal contract award is for PROLASTIN-C, a pharmaceutical product, awarded by the Department of Veterans Affairs Veterans Health Administration to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The $355,273.02 firm fixed price delivery order is under the Pharmaceuticals and Drugs GSA Schedule contract vehicle and does not utilize any small business set-asides. Grifols Therapeutics has previously been awarded other federal...

The Defense Logistics Agency awarded a $15,904.35 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 1,000 mg/20 ml vials of PROLASTIN C. The place of performance is Park Ridge, Illinois. The contract period runs from June 16, 2023 to July 11, 2023. As the DLA supports military readiness by procuring and delivering medical supplies, this award will provide the requested pharmaceutical product to support the agency's mission. No major subcontractors or set aside designations...

Grifols USA LLC was awarded an $11,580.80 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21. The delivery order, which has no set-aside designation and a completion date of June 13, 2023, is for the purchase of PROLASTIN-C. Performance will take place in Los Angeles, California. The contract utilizes firm fixed pricing and draws from GSA Schedule 61-IB to...

This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract is for the supply of PROLASTIN-C PHARMACEUTICALS and is issued under the VA's Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB). The contract has a ceiling value of $94,800.00 and a period of performance ending on September 30, 2015. The contract does not utilize any small...